Galsulfase
Naglazyme (galsulfase) is an enzyme pharmaceutical. Galsulfase was first approved as Naglazyme on 2005-05-31. It is used to treat mucopolysaccharidosis VI in the USA. It has been approved in Europe to treat mucopolysaccharidosis VI.
| Trade Name | Naglazyme |
|---|---|
| Common Name | Galsulfase |
| Indication | mucopolysaccharidosis vi |
| Drug Class | Enzymes |
